Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Access Site Complication”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Not applicableAvailableNCT06443944
What this trial is testing

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

Who this might be right for
Non-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more
CG Oncology, Inc.
Not applicableLooking for participantsNCT06128304
What this trial is testing

ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

Who this might be right for
HIVCervical Cancer
University of California, San Diego 2,436
Not applicableStudy completedNCT01412671
What this trial is testing

Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program

Who this might be right for
Carcinoma, Renal Cell
Bayer 117
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Not applicableApproved For MarketingNCT03079687
What this trial is testing

Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Who this might be right for
Ovarian Cancer
AstraZeneca
Not applicableNot Yet RecruitingNCT07557862
What this trial is testing

Multi-Site STARgraft (10401) Trial

Who this might be right for
End Stage Renal Disease (ESRD)
Healionics Corporation 75
Not applicableLooking for participantsNCT04077762
What this trial is testing

Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)

Who this might be right for
Patient SatisfactionVascular Access Complication
Minneapolis Heart Institute Foundation 3,266
Not applicableStudy completedNCT00597363
What this trial is testing

Neptune Pad ® Compared to Conventional Manual Compression

Who this might be right for
Postoperative Hemorrhage
Vienna General Hospital 201
Not applicableUnknownNCT04689451
What this trial is testing

Feasibility and Safety of Total Percutaneous Closure of Femoral Arterial Access Sites in the Veno-arterial ECMO Patients

Who this might be right for
Cardiogenic ShockExtracorporeal Membrane OxygenationMyocarditis+4 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 40
Not applicableNo Longer AvailableNCT04060628
What this trial is testing

Expanded Access to NanoDoce

Who this might be right for
Urogenital Neoplasms
NanOlogy, LLC
Not applicableNo Longer AvailableNCT03554434
What this trial is testing

An Expanded Access Program for AM0010 (Pegilodecakin)

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company
Not applicableStudy completedNCT00531544
What this trial is testing

A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248

Who this might be right for
Metastatic Renal Cell Carcinoma
King Faisal Specialist Hospital & Research Center 350
Not applicableEnrolling By InvitationNCT05528237
What this trial is testing

HPV Self-sampling to Improve Access to Cervical Cancer Screening for Persons With HIV and/or Underserved Individuals

Who this might be right for
Cervical Cancer
University of Washington 50
Not applicableNot Yet RecruitingNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Testing effectiveness (Phase 2)Study completedNCT03012620
What this trial is testing

Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types

Who this might be right for
SarcomaOvarian NeoplasmCentral Nervous System Neoplasm+4 more
UNICANCER 334
Not applicableUnknownNCT05156008
What this trial is testing

Comparison of Ultrasound-guided and Palpation-inserted Peripheral Venous Cannula

Who this might be right for
Vascular Access ComplicationVascular Access Site Bruising
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica 200
Not applicableNo Longer AvailableNCT00655252
What this trial is testing

Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy

Who this might be right for
Metastatic Renal Cell Cancer
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00003624
What this trial is testing

Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+4 more
Gynecologic Oncology Group
Not applicableNot Yet RecruitingNCT07294066
What this trial is testing

Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina

Who this might be right for
Cervix CancerScreen HPV-positive
UNC Lineberger Comprehensive Cancer Center 112
Load More Results